The hiCare suite of innovative products for chronic disease management, medication adherence, and telemedicine was exhibited at ATA

Factors, such as growing incidence of cancer cases and lifestyle diseases globally, the cost-effectiveness of biosimilars over biologics, and strategic collaboration to develop new biosimilar drugs will increase the market growth during the forecast period.